Anticancer activity of esculetin via-modulation of Bcl-2 and NF-?B expression in benzo[a]pyrene induced lung carcinogenesis in mice - 15/06/13
Abstract |
Esculetin (ESC), a coumarin derivative, has shown to possess antioxidant, anti-inflammatory, anticancer and chemopreventive properties. In the present study, we evaluated the chemopreventive activity of ESC against benzo[a]pyrene (B[a]P) induced lung carcinogenesis in Swiss albino mice by measuring antioxidant parameter, like lipid peroxidation, reduced glutathione (GSH) and superoxide dismutase (SOD); and levels of Bcl-2 and NF-κB protein in lung tissues. Lung carcinogenesis was induced by B[a]P (50mg/kg, intraperitoneally). Pre-treatment and post-treatment groups were treated with ESC (50mg/kg, per oral). Oxidative stress-induced by B[a]P was decreased by ESC. Anti-apoptotic protein Bcl-2 and pleotropic regulator NF-κB are found to possess oncogenic roles in B[a]P induced carcinogenesis. Western blot analysis study showed alleviated levels Bcl-2 and NF-κB in ESC pre-treated and post-treated groups in comparison to B[a]P treated group. These results suggest the anti-initiating and apoptosis inducing property of ESC on pre- and post-treatment in B[a]P induced lung carcinogenesis in Swiss albino mice.
Le texte complet de cet article est disponible en PDF.Keywords : Esculetin, Benzo[a]pyrene, Bcl-2, NF-κB, Chemoprevention
Plan
Vol 3 - N° 2
P. 107-112 - avril 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?